Cardiac myoblasts, integral to the cardiovascular system, play a vital role in the intricate dance of heart functionality. As specialized muscle cells, they contribute significantly to cardiac development during embryogenesis, intricately weaving the essential muscle fibers that form the foundation for effective blood pumping. Beyond their critical role in heart development, these cells are garnering attention in the realm of regenerative medicine. Researchers are actively exploring the potential of cardiac myoblasts to serve as a regenerative force, particularly in the repair of damaged heart tissue. The unique ability of cardiac myoblasts to mature into functional cardiac muscle cells positions them as a promising avenue for therapeutic interventions, with the potential to revolutionize approaches to treating cardiovascular diseases. Ongoing studies in this field hold the key to uncovering innovative strategies that could redefine the landscape of cardiac regenerative medicine.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States